Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

How drug companies are sidestepping the WHO’s technology transfer hub in Africa

How drug companies are sidestepping the WHO’s technology transfer hub in Africa

PHARMACEUTICAL company Moderna announced on 7 March 2022 that it would develop a site in Kenya to manufacture COVID-19 vaccines. The company holds much of the key intellectual property relating to the messenger RNA (mRNA) vaccines. Due to their higher efficacy, mRNA vaccines are the preferred option in developed countries. They account for 92% of all vaccinations to date in the US and European Union. Author DAVID RICHARD WALWYN, Professor of Technology Management, University of Pretoria Moderna’s decision to continue making the vaccine itself, though on the Kenyan site, is a signal that the company (at least for the moment)…
Read More